KIT and systemic mastocytosis: However, from an ontogenetic point of view, it is known that pathological MCs from the vast majority of patients (>90%) carries the D816V mutation in the KIT protooncogene [8,9] regardless of the diagnostic subtype of SM and its clinical course (e.g., Non-AdvSM or AdvSM).